MaRS Discovery District · Toronto, ON
AI & SEO consulting at MaRS,
for health tech and research spinouts.
AI consulting, commercialization support, and digital strategy for MaRS Discovery District tenants — health tech startups, research spinouts, JLABS residents, and Vector Institute-adjacent teams. Built for the constraints of health, hospital, and academic spinout work.
The Neighborhood
MaRS Discovery District: Canada's innovation and health-tech anchor
MaRS Discovery District is a place and a project. The place is the MaRS Centre at 101 College Street, just north of Queen's Park and directly adjacent to the University of Toronto downtown campus and the University Health Network (UHN) hospital complex — Toronto General, Toronto Western, Princess Margaret, and Mount Sinai Hospital. The project is one of the largest urban innovation hubs in the world, a 1.5 million square foot complex that houses the Vector Institute for artificial intelligence research, JLABS @ Toronto (Johnson & Johnson's health-tech incubator), Toronto Innovation Acceleration Partners, Trillium Health Partners' research operations, and hundreds of early-stage and scaling tenant companies across health, cleantech, AI, fintech, and enterprise software.
The tenant mix is unlike anything else in Canada. Vector Institute operates from the MaRS Centre, making it the gravity well for Canadian AI research talent. JLABS @ Toronto brings Johnson & Johnson's global network to early-stage digital health and medtech startups. Toronto Innovation Acceleration Partners runs hospital-founded commercialization across UHN, Sinai, and the Hospital for Sick Children. The direct adjacency to the UHN hospitals — you can walk from a MaRS office to a Toronto General clinical unit in under 10 minutes — is one of the strongest health-tech translation advantages globally. A startup incubated at MaRS can have a clinical pilot running in a UHN department within a year in ways that no other Canadian hub can match.
What distinguishes MaRS from King West tech (media, agency, growth-stage SaaS) or Bay Street finance (governance-heavy enterprise) is the commercialization stage and the regulatory complexity. MaRS tenants are often pre-revenue or just past it. They are figuring out their first clinical pilot, their first hospital procurement cycle, their first regulatory filing, their first go-to-market messaging. They are also navigating a specific kind of constraint — PHIPA, REB and IRB approvals, hospital procurement committees, tech-transfer offices, pharma partnership contracts — that most tech consultants do not understand. That shapes the engagement shape for every MaRS-tenant client.
Local Pain Points
Pain points specific to MaRS health tech and research spinouts
These are the patterns we hear from MaRS tenants, UHN-affiliated spinouts, Vector-adjacent teams, and JLABS residents. The common thread is commercialization-stage health tech where scientific credibility is present but operational and go-to-market capacity is thin.
We pick the highest-leverage fix for your MaRS Discovery District business first — not whatever we can bill for longest.
What we hear from MaRS Discovery District operators
- Hospital procurement-friendly positioning — startups with strong science who cannot get past a hospital procurement committee because the materials do not answer the questions those committees actually ask
- Clinical pilot operational tooling — research teams running their first or second UHN or Sinai pilot with consent tracking, site coordination, and data-capture workflows built in a spreadsheet
- Research-operations AI pipelines — literature retrieval, protocol drafting, REB and IRB submission drafts, and grant application workflows consuming research-team time that should be on the science
- Go-to-market content for regulated categories — health tech and medtech marketing that has to pass both a procurement review and a regulatory tone check without feeling sterile
- Investor pitch narratives for health-tech specific expectations — MaRS founders pitching to health-tech VCs (F-Prime, OMERS, BDC Health, pharma corporate venture) who want different materials than a pure SaaS deck
- Founder operational overhead in a PHIPA-governed environment — CEOs juggling commercialization, regulatory, hospital partnerships, and internal ops with no COO in sight
What we do here
What we build for MaRS tenants and health-tech spinouts
Our MaRS work is narrower and deeper than our general tech book. We are specific about what we do and do not touch. We do not build core clinical AI models or advise on regulatory affairs. We do build the commercialization layer around science-led teams — positioning, hospital procurement materials, research-operations AI, and the investor narrative that gets funded.
Looking for city-wide services?
Broader Toronto service pages
This page covers the MaRS Discovery District picture specifically. If you want the full scope of how we work across Toronto, head to the city-level pages below.
Industries
Industries we serve in MaRS Discovery District
A deeper industry view, including case studies and specific workflows we have built.
FAQ
Common questions from MaRS Discovery District businesses
Other Toronto neighborhoods
Explore the rest of Toronto
Ready to commercialize your MaRS-tenant health tech or research spinout?
Book a free 30-minute call. We will scope the commercialization gap honestly — hospital procurement, research operations, investor narrative, or all three — and tell you whether we are the right fit.
Serving MaRS Discovery District and the rest of Toronto, Ontario.